buprenorphinum 30 mg, oleylis oleas, povidonum K 90, acidum laevulinicum, acrylates et vinylis acetatis polymerisatum (vernetzt), poly(ethylenis terephthalas), acrylates et vinylis acetatis polymerisatum (nicht vernetzt), Trägermaterial: poly(ethylenis terephthalas), ad praeparationem pro 37.5 cm², cum liberatione 52.5 µg/h.
Packungsbestandteile
Transdermale Pflaster
Active Agent
Dose
Buprenorphine
30 mg
BAG: Active Agent
Dose
Buprenorphine
30 mg
Source
Data was imported : 04.02.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
